Low climate-impact corticosteroid inhalers are as effective as high climate impact inhalers for COPD and asthma outcomes, per ...

Long COVID occurs in approximately a third of COVID-19 survivors, with the CDC estimating one in 13 adults in the United ...

Respiratory medicine is one frontier of the global healthcare landscape which has undergone significant transformations in ...

Caroline Quill, MD, of the University of Rochester Medical Center, highlighted the potential of artificial intelligence (AI) ...

The longer you smoke, the more you risk causing chronic inflammation or swelling in the lungs and the greater your risk of developing lung cancer, including lung cancer and COPD ... breathing ...

Extrafine single inhaler triple therapy is effective among patients with COPD who were previously treated with multiple-inhaler triple therapy.

The label expansion provides a new option for the hundreds of thousands of Americans with inadequately controlled COPD.

Distinct patterns of symptom severity among patients with COPD sheds light on the heterogeneous nature of the patients’ ...

Background Clinical studies have shown that glucagon-like peptide-1 receptor agonists (GLP-1 RA) can have beneficial effects ...

The FDA has approved Dupixent (dupilumab) as an add-on therapy for adults with poorly controlled COPD, especially those with ...

RESPICON 2024 organised between 27th and 29th September witnessed a significant milestone in the field of pulmonary medicine ...

China NMPA approves Sanofi & Regeneron’s Dupixent as an add-on maintenance treatment for adults with uncontrolled COPD: Paris Monday, September 30, 2024, 11:00 Hrs [IST] The Nat ...